Description
PRIORIX ONE DOSE VIAL+DILUENT: Your Protection Against Measles, Mumps, and Rubella
Safeguard your health with PRIORIX ONE DOSE VIAL+DILUENT, a vital vaccine available in a convenient one-dose vial accompanied by its diluent. This live virus vaccine actively immunizes individuals against three highly contagious viral diseases: measles, mumps, and rubella.
Understanding the Importance of PRIORIX
PRIORIX works by introducing weakened versions of the measles, mumps, and rubella viruses into your body. This exposure stimulates your immune system to produce antibodies, which are your body’s natural defense against these specific viruses. Consequently, if you encounter these viruses in the future, your immune system will remember them and quickly fight them off, preventing you from getting sick. Vaccination with PRIORIX is a safe and effective way to achieve long-lasting immunity.
Key Components Working Together
Each dose of PRIORIX contains specific live attenuated (weakened) virus strains for each of the targeted diseases:
- Measles Virus (Schwarz strain): This component protects against measles, a highly infectious disease causing fever, rash, cough, and potentially serious complications.
- Mumps Virus (RIT 4385 strain, derived from Jeryl Lynn strain): This component provides immunity against mumps, characterized by swollen salivary glands, fever, and other symptoms.
- Rubella Virus (Wistar RA 27/3 strain): This component protects against rubella, also known as German measles, which can be particularly dangerous for pregnant women and their unborn babies.
Formulation and Preparation for Use
PRIORIX comes as a lyophilized (freeze-dried) powder in a single-dose vial. To prepare the vaccine for injection, you must reconstitute it with the accompanying sterile diluent. The diluent is typically sterile water, provided in a separate ampoule or pre-filled syringe. Healthcare professionals will carefully mix the diluent with the powder in the vial to create the ready-to-inject solution. The reconstituted vaccine appears as a clear, peach to fuchsia pink colored liquid.
Administration and Recommended Dosage
Healthcare providers administer PRIORIX via subcutaneous injection (under the skin), although they can also give it as an intramuscular injection (into the muscle) in the upper arm or thigh. The standard dose for individuals from 12 months of age and older is a single 0.5 mL injection after reconstitution. Often, healthcare providers recommend a two-dose schedule to ensure optimal protection against measles, mumps, and rubella. The first dose usually occurs around 12 to 15 months of age, with the second dose typically given between 4 and 6 years of age.
Why Choose PRIORIX for MMR Protection?
Selecting PRIORIX for measles, mumps, and rubella vaccination offers several important advantages:
- Effective Protection: PRIORIX has a well-established record of effectively preventing these three contagious diseases.
- Convenient Combination: This vaccine provides protection against all three diseases in a single injection, reducing the number of shots needed.
- Trusted and Widely Used: Healthcare professionals worldwide have used PRIORIX for many years as a reliable MMR vaccine.
- Supports Public Health: By getting vaccinated with PRIORIX, you contribute to herd immunity, protecting vulnerable individuals who cannot receive the vaccine.
In conclusion, PRIORIX ONE DOSE VIAL+DILUENT is a crucial vaccine that actively protects individuals from the serious health risks associated with measles, mumps, and rubella. Its formulation as a single-dose vial with diluent ensures proper preparation and dosage. By choosing PRIORIX, you are taking a responsible step towards safeguarding your health and the health of your community. Consult your healthcare provider to determine the appropriate PRIORIX vaccination schedule for yourself or your child.
